Article Information
- Received September 28, 2000
- Revision received April 3, 2001
- Accepted April 4, 2001
- First published June 15, 2001.
- Version of record published June 15, 2001.
Author Information
- Nobuki Matsuura1,
- D. Chichung Lie2,
- Minoru Hoshimaru1,
- Minoru Asahi1,
- Masato Hojo1,
- Ryuji Ishizaki1,
- Nobuo Hashimoto1,
- Sumihare Noji3,
- Hideyo Ohuchi3,
- Hidefumi Yoshioka3, and
- Fred H. Gage2
- 1Department of Neurosurgery, Kyoto University Graduate School of Medicine, 606-8507 Kyoto, Japan,
- 2Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037, and
- 3Department of Biological Science and Technology, Faculty of Engineering, University of Tokushima, 770-0042 Tokushima, Japan
Author contributions
Disclosures
- Received September 28, 2000.
- Revision received April 3, 2001.
- Accepted April 4, 2001.
This research was supported in part by Ministry of Education, Science, and Culture of Japan Grant-in-Aid 08671578, the Japan Epilepsy Research Foundation, and the Cell Science Research Foundation. F.H.G. is supported by National Institutes of Health Grant AG08514, the Lookout Fund, and the National Parkinson Foundation. D.C.L. is supported by the Deutsche Forschungsgemeinschaft. We thank M. Gage for helpful critique of this manuscript and Linda Kitabayashi and Steve Forbes for excellent technical assistance. The SHH-blocking antibody was obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA).
N.M. and D.C.L. contributed equally to this work.
Correspondence should be addressed to Dr. Fred H. Gage, The Salk Institute, Laboratory of Genetics, 10010 North Torrey Pines Road, La Jolla, CA 92037. E-mail: fgage{at}salk.edu.
Online Impact